论文部分内容阅读
目的观察并比较热毒宁与利巴韦林治疗小儿急性上呼吸道感染疗效及症状缓解方面的差异。方法 230例急性上呼吸道感染的患儿随机分为治疗组与对照组,治疗组给予热毒宁治疗,对照组给予利巴韦林。结果治疗组在临床症状及体征改善、痊愈时间、显效率等方面显著优于对照组,且无明显不良反应,但在缓解鼻塞及流涕方面疗效不明显。结论热毒宁注射液治疗儿童呼吸道感染疗效显著,值得推广,但仍需配合其他药物缓解鼻塞及流涕症状。
Objective To observe and compare the difference between the efficacy and the relief of rebleeding and ribavirin in the treatment of pediatric acute upper respiratory tract infection. Methods 230 cases of children with acute upper respiratory tract infection were randomly divided into treatment group and control group. The treatment group was treated with Renduining, while the control group was given ribavirin. Results The treatment group was significantly better than the control group in improving clinical symptoms and signs, recovery time, significant efficiency and no obvious adverse reactions, but the curative effect was not obvious in relieving nasal obstruction and runny nose. Conclusion Revedunin injection has a significant therapeutic effect on respiratory tract infections in children and is worth promoting. However, it is necessary to cooperate with other drugs to relieve the symptoms of nasal congestion and runny nose.